Skip to content

{ Tag Archives } Llc

Wound Management Technologies Announces Cytokine Study Presentation At The Tri-Society Annual Conference 2009 In Lisbon, Portugal

Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc.

Bookmark and Share Also tagged , , , , , ,

Wound Management Technologies Announces Clinical Study Presentation Of CellerateRx(R) Technology At Leading Skin And Wound Care Conference

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced that its subsidiary Wound Care Innovations, LLC will exhibit at the 24th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing, which opens on October 22 in San Antonio. [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , ,

Reveal Sciences Launches At-Home Skin Typing And Analysis Kit For Consumers

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit. Developed by physician Damon Borich, M.D., CEO of Reveal Sciences, and his scientific team, the novel skincare analysis technology is the next-generation spin-off from the company’s professional [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , ,

Merz Pharmaceuticals’ Belotero(R) Balance PMA Filing Formally Accepted For Review By The FDA

Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz’s premarket approval (PMA) application for Belotero(R) Balance. Belotero(R) Balance is a hyaluronic acid based monophasic gel dermal filler that utilizes a cohesive polydensified matrix (CPM(TM)) technology.

Bookmark and Share Also tagged , , , , , , , , , ,

IMULAN Prepares To Initiate Trials For Atopic Dermatitis In Dogs

IMULAN BioTherapeutics, LLC announced they are prepared to commence with regulated trials to complete work on the T-Cell Receptor peptide immunomodulator, for atopic dermatitis in dogs. Canine atopic dermatitis is a very prevalent condition in dogs, thought to affect up to 5 percent of the dog population. Clinical signs of atopic dermatitis include pruritus (itching) [...]

Bookmark and Share Also tagged , , , , , , , , , , , ,

Wound Management Technologies, Inc. Announces The Presentation Of Evidence Based Clinical Studies At The Symposium On Advanced Wound Care

Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it will exhibit at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) conference in Dallas April 26-29. This conference is regarded industry wide as the premier educational wound-care focused program and has [...]

Bookmark and Share Also tagged , , , , , , , , , ,

American Biotech Labs(R) Obtains FDA Approval For New Wound Care Gel Product

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company’s patented nano-catalytic SilverSol Technology(R), announced that the company has been granted formal approval by the U.S. Food and Drug Administration (FDA) to market its ASAP Wound Dressing Gel throughout the United States.

Bookmark and Share Also tagged , , , , , , , , , , , ,